Photodynamic therapy induced Fas-mediated apoptosis in human carcinoma cells

Int J Mol Med. 2002 Mar;9(3):257-70.

Abstract

Photodynamic therapy (PDT) is a clinical approach that utilizes light-activated drugs for the treatment of a variety of pathologic conditions. Human poorly (CNE2) and moderately differentiated (TW0-1) human nasopharyngeal carcinoma (NPC) cells undergo rapid apoptosis when treated with PDT sensitized with Hypocrellin A (HA) and Hypocrellin B (HB). It has been shown that these compounds have a strong photodynamic effect on tumors and viruses. The initiating events of PDT sensitized HA and HB-induced apoptosis are poorly defined. In the current study, we sought to determine whether Fas/FasL upregulation and involvement of mitochondrial events are an early event in HA and HB-treated PDT induced apoptosis. Loss of mitochondrial transmembrane potential, release of cytochrome c, involvement of caspases-8 and -3 and the status caspase-3 specific substrate PARP, were evaluated in PDT treated tumor cells. Photoactivation of HA and HB enhanced both CD95/CD95L expression and induced CD95-signaling dependent cell death in all tumor cell lines studied. CD95/ CD95L expression appeared within 2 h following light activation and appeared to be a primary event in PDT induced apoptosis. Furthermore, these results indicate that release of mitochondrial cytochrome c into the cytoplasm is a secondary event following the activation of initiator caspase-8 preceding caspase-3 activation, cleavage of PARP and DNA fragmentation. Cytochrome c appeared in the cytosol within 2-3 h post PDT. Cleavage of PARP was observed at 3-4 h following PDT and caspase-3 specific inhibitor DEVD-CHO and broad-spectrum caspases inhibitor z-VAD-fmk blocked caspase-3 activation and PARP cleavage suggesting that caspase-3 plays an important role in HA and HB-induced apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Carcinoma / metabolism
  • Carcinoma / pathology*
  • Carcinoma / therapy*
  • Caspase 3
  • Caspases / metabolism
  • Cytochrome c Group / metabolism
  • Fas Ligand Protein
  • Humans
  • Membrane Glycoproteins / metabolism
  • Membrane Potentials / drug effects
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Nasopharyngeal Neoplasms / metabolism
  • Nasopharyngeal Neoplasms / pathology*
  • Nasopharyngeal Neoplasms / therapy*
  • Perylene / administration & dosage*
  • Perylene / analogs & derivatives*
  • Phenol
  • Photochemotherapy*
  • Photosensitizing Agents / administration & dosage*
  • Quinones / administration & dosage*
  • Tumor Cells, Cultured
  • fas Receptor / metabolism*

Substances

  • Cytochrome c Group
  • FASLG protein, human
  • Fas Ligand Protein
  • Membrane Glycoproteins
  • Photosensitizing Agents
  • Quinones
  • fas Receptor
  • Phenol
  • Perylene
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • hypocrellin A